Skip to main content

OraVerse FDA Approval History

FDA Approved: Yes (First approved May 9, 2008)
Brand name: OraVerse
Generic name: phentolamine mesylate
Dosage form: Injection
Company: Novalar Pharmaceuticals, Inc.
Treatment for: Reversal of Anesthesia

OraVerse is a dental anesthetic reversal agent that accelerates the return to normal sensation and function following dental procedures.

Development timeline for OraVerse

May 12, 2008Approval Novalar Pharmaceuticals, Inc. Receives FDA Approval for OraVerse

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.